Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2019

Published	Pages	Publisher	Report code
Mar 2019	96	Global Markets Direct	ASDR-483185

Published: Mar 2019 - Pages : 96 - Publisher : Global Markets Direct - Report code : ASDR-483185

Chipscreen Biosciences Ltd
CymaBay Therapeutics Inc
Genfit SA
Inception Sciences Inc
Inventiva
Mitobridge Inc
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc

Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019

This report can be of interest as well:

Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019

Published: August, 2019 | Report code: ASDR-491582